Cleavage of Structured RNAs Is Accelerated by High Affinity DNAzyme Agents

Area of Science:

• Molecular Biology
• Biochemistry
• Therapeutic RNA Targeting

Background:

• DNAzymes (Dz) are explored for sequence-specific RNA cleavage in therapeutics.
• Traditional Dz designs face challenges with efficiently cleaving folded RNA substrates due to low binding affinity.
• Existing strategies for enhancing cleavage efficiency have limitations in substrate turnover and product inhibition.

Purpose of the Study:

• To discuss challenges in designing DNAzymes (Dz) for effective cleavage of folded RNA.
• To propose strategies for improving Dz affinity and catalytic efficiency for therapeutic RNA inhibition.
• To suggest modifications in Dz design algorithms for enhanced in vitro and in vivo applications.

Main Methods:

• Conceptual analysis of DNAzyme (Dz) design principles for RNA targeting.
• Discussion of strategies including high-affinity arms, bivalent/multivalent constructs, and RNase H co-treatment.
• Evaluation of factors influencing Dz:RNA complex stability, selectivity, and substrate turnover.

Main Results:

• High-affinity arms can facilitate RNA cleavage but may lead to product inhibition.
• Bivalent and multivalent DNAzyme (Dz) constructs with multiple catalytic cores enhance RNA binding and turnover.
• RNase H stabilizes the Dz:RNA complex, increasing cleavage efficiency at the cost of selectivity.

Conclusions:

• Optimized DNAzyme (Dz) design requires balancing binding affinity, catalytic efficiency, and selectivity.
• Proposed design modifications and the use of co-factors like RNase H can lead to potent RNA inhibition agents.
• Enhanced DNAzyme (Dz) designs hold promise for therapeutic RNA targeting in cellular and in vivo models.